
Lansoprazole Delayed Release Capsules Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 15 mg and 30 mg
Reference Brands: Prevacid(US & EU)
Category: Gastrointestinal Drugs
Lansoprazole Delayed release Capsules is available in Capsules and strengths such as 15 mg and 30 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lansoprazole Delayed release Capsules is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Lansoprazole Delayed release Capsules can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Lansoprazole capsules, marketed as Prevacid, are approved in the US by the FDA and in the EU via EMA for GERD, erosive esophagitis, and Zollinger-Ellison syndrome. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety profiles, manufacturing quality, and pharmacovigilance plans. The FDA reviews detailed clinical trial and manufacturing data for timely approval, while the EMA ensures compliance with regional safety and quality standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Adherence to regional regulations supports swift approval, safe medication use, and global availability, helping millions worldwide effectively manage acid-related disorders.
Frequently Asked Questions
Related Products
Pancreatin Tablets
Strength:
10,000, 25,000, 40,000, 50,000, 80,000 USP units.
Form: Tablets
Reference Brands: Creon(US)
View DetailsUrsodeoxycholic Acid Capsule
Strength:
150 mg, 300 mg
Form: Capsules
Reference Brands: Actigall(US), rsofalk, Ursocaps, Ursode(EU)
View DetailsQuick Response Guaranteed | Verified Suppliers